Cargando…

Exploring the In Vitro Thrombolytic Activity of Nattokinase From a New Strain Pseudomonas aeruginosa CMSS

BACKGROUND: Thrombolytic therapy has become a conventional treatment for acute myocardial infarction (AMI), yet currently, clinically prescribed thrombolytic drugs have problems such as delayed action and other side effects. Fibrinolytic enzymes have attracted interest as thrombolytic agents because...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandrasekaran, Subathra Devi, Vaithilingam, Mohanasrinivasan, Shanker, Ravi, Kumar, Sanjeev, Thiyur, Swathi, Babu, Vaishnavi, Selvakumar, Jemimah Naine, Prakash, Suyash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644271/
https://www.ncbi.nlm.nih.gov/pubmed/26587211
http://dx.doi.org/10.5812/jjm.23567
_version_ 1782400645424218112
author Chandrasekaran, Subathra Devi
Vaithilingam, Mohanasrinivasan
Shanker, Ravi
Kumar, Sanjeev
Thiyur, Swathi
Babu, Vaishnavi
Selvakumar, Jemimah Naine
Prakash, Suyash
author_facet Chandrasekaran, Subathra Devi
Vaithilingam, Mohanasrinivasan
Shanker, Ravi
Kumar, Sanjeev
Thiyur, Swathi
Babu, Vaishnavi
Selvakumar, Jemimah Naine
Prakash, Suyash
author_sort Chandrasekaran, Subathra Devi
collection PubMed
description BACKGROUND: Thrombolytic therapy has become a conventional treatment for acute myocardial infarction (AMI), yet currently, clinically prescribed thrombolytic drugs have problems such as delayed action and other side effects. Fibrinolytic enzymes have attracted interest as thrombolytic agents because of their efficiency in the fibrinolytic process, including plasmin activation. Nattokinase (NK) is a potent fibrinolytic agent for thrombosis therapy. OBJECTIVES: The aim of this study was to enhance the production of NK from Pseudomonas aeruginosa CMSS by media optimization and strain improvement. MATERIALS AND METHODS: In the present study, a potent NK-producing strain was isolated from cow milk and identified. To enhance the yield of NK, effect of various parameters such as pH, temperature, carbon source, nitrogen source and inoculum size were optimized. Strain improvement of P. aeruginosa CMSS was done by random UV-mutagenesis. Nattokinase was partially purified and the activity was determined by the casein digestion method, blood clot lysis and fibrin degradation assay. RESULTS: Based on morphological, biochemical and molecular characterization, the strain was confirmed as P. aeruginosa (GenBank accession number: JX112657), designated as P. aeruginosa CMSS. The optimum condition at pH 7 and temperature at 25˚C showed activity of NK as 1514 U mL(-1) and 1532 U mL(-1), respectively. Sucrose as the carbon source and shrimp shell powder (SSP) as the nitrogen source expressed NK activity of 1721 U mL(-1) and 2524 U mL(-1), respectively. At 1% inoculum size, the maximum rate of enzyme production was achieved with 2581 U mL(-1). The NK activity of the mutant strain UV60 was 4263 U mL(-1), indicating a two-fold increase in activity compared to the wild strain (2581 UmL(-1)). Nattokinase produced from mutant strain P. aeruginosa CMSS UV60 showed 94% blood clot lysis at ten minutes. The degradation of fibrin clot by the produced NK was observed after two hours of incubation. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) confirmed the molecular mass of CMSS UV60 NK to be 21kDa. CONCLUSIONS: The current study demonstrated the enhanced production of NK by P. aeruginosa CMSS. This study is unique and the findings are the first report on the production of NK from P. aeruginosa CMSS isolated from cow milk.
format Online
Article
Text
id pubmed-4644271
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-46442712015-11-19 Exploring the In Vitro Thrombolytic Activity of Nattokinase From a New Strain Pseudomonas aeruginosa CMSS Chandrasekaran, Subathra Devi Vaithilingam, Mohanasrinivasan Shanker, Ravi Kumar, Sanjeev Thiyur, Swathi Babu, Vaishnavi Selvakumar, Jemimah Naine Prakash, Suyash Jundishapur J Microbiol Research Article BACKGROUND: Thrombolytic therapy has become a conventional treatment for acute myocardial infarction (AMI), yet currently, clinically prescribed thrombolytic drugs have problems such as delayed action and other side effects. Fibrinolytic enzymes have attracted interest as thrombolytic agents because of their efficiency in the fibrinolytic process, including plasmin activation. Nattokinase (NK) is a potent fibrinolytic agent for thrombosis therapy. OBJECTIVES: The aim of this study was to enhance the production of NK from Pseudomonas aeruginosa CMSS by media optimization and strain improvement. MATERIALS AND METHODS: In the present study, a potent NK-producing strain was isolated from cow milk and identified. To enhance the yield of NK, effect of various parameters such as pH, temperature, carbon source, nitrogen source and inoculum size were optimized. Strain improvement of P. aeruginosa CMSS was done by random UV-mutagenesis. Nattokinase was partially purified and the activity was determined by the casein digestion method, blood clot lysis and fibrin degradation assay. RESULTS: Based on morphological, biochemical and molecular characterization, the strain was confirmed as P. aeruginosa (GenBank accession number: JX112657), designated as P. aeruginosa CMSS. The optimum condition at pH 7 and temperature at 25˚C showed activity of NK as 1514 U mL(-1) and 1532 U mL(-1), respectively. Sucrose as the carbon source and shrimp shell powder (SSP) as the nitrogen source expressed NK activity of 1721 U mL(-1) and 2524 U mL(-1), respectively. At 1% inoculum size, the maximum rate of enzyme production was achieved with 2581 U mL(-1). The NK activity of the mutant strain UV60 was 4263 U mL(-1), indicating a two-fold increase in activity compared to the wild strain (2581 UmL(-1)). Nattokinase produced from mutant strain P. aeruginosa CMSS UV60 showed 94% blood clot lysis at ten minutes. The degradation of fibrin clot by the produced NK was observed after two hours of incubation. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) confirmed the molecular mass of CMSS UV60 NK to be 21kDa. CONCLUSIONS: The current study demonstrated the enhanced production of NK by P. aeruginosa CMSS. This study is unique and the findings are the first report on the production of NK from P. aeruginosa CMSS isolated from cow milk. Kowsar 2015-10-26 /pmc/articles/PMC4644271/ /pubmed/26587211 http://dx.doi.org/10.5812/jjm.23567 Text en Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Chandrasekaran, Subathra Devi
Vaithilingam, Mohanasrinivasan
Shanker, Ravi
Kumar, Sanjeev
Thiyur, Swathi
Babu, Vaishnavi
Selvakumar, Jemimah Naine
Prakash, Suyash
Exploring the In Vitro Thrombolytic Activity of Nattokinase From a New Strain Pseudomonas aeruginosa CMSS
title Exploring the In Vitro Thrombolytic Activity of Nattokinase From a New Strain Pseudomonas aeruginosa CMSS
title_full Exploring the In Vitro Thrombolytic Activity of Nattokinase From a New Strain Pseudomonas aeruginosa CMSS
title_fullStr Exploring the In Vitro Thrombolytic Activity of Nattokinase From a New Strain Pseudomonas aeruginosa CMSS
title_full_unstemmed Exploring the In Vitro Thrombolytic Activity of Nattokinase From a New Strain Pseudomonas aeruginosa CMSS
title_short Exploring the In Vitro Thrombolytic Activity of Nattokinase From a New Strain Pseudomonas aeruginosa CMSS
title_sort exploring the in vitro thrombolytic activity of nattokinase from a new strain pseudomonas aeruginosa cmss
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644271/
https://www.ncbi.nlm.nih.gov/pubmed/26587211
http://dx.doi.org/10.5812/jjm.23567
work_keys_str_mv AT chandrasekaransubathradevi exploringtheinvitrothrombolyticactivityofnattokinasefromanewstrainpseudomonasaeruginosacmss
AT vaithilingammohanasrinivasan exploringtheinvitrothrombolyticactivityofnattokinasefromanewstrainpseudomonasaeruginosacmss
AT shankerravi exploringtheinvitrothrombolyticactivityofnattokinasefromanewstrainpseudomonasaeruginosacmss
AT kumarsanjeev exploringtheinvitrothrombolyticactivityofnattokinasefromanewstrainpseudomonasaeruginosacmss
AT thiyurswathi exploringtheinvitrothrombolyticactivityofnattokinasefromanewstrainpseudomonasaeruginosacmss
AT babuvaishnavi exploringtheinvitrothrombolyticactivityofnattokinasefromanewstrainpseudomonasaeruginosacmss
AT selvakumarjemimahnaine exploringtheinvitrothrombolyticactivityofnattokinasefromanewstrainpseudomonasaeruginosacmss
AT prakashsuyash exploringtheinvitrothrombolyticactivityofnattokinasefromanewstrainpseudomonasaeruginosacmss